Unmet needs and future questions in cellular therapy for myeloma

Adam Cohen, MD, University of Pennsylvania, Philadelphia, PA, highlights key unmet needs in cellular therapy for multiple myeloma, including the need to improve manufacturing processes and patient responses, as well as better mitigate toxicities associated with CAR-T products. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.